VentriPoint Diagnostics Ltd.
VPTDF
$0.08
-$0.006-6.98%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.70K | 0.00 | 47.30K | 22.40K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.70K | 0.00 | 47.30K | 22.40K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 49.70K | 0.00 | 47.30K | 22.40K | -- |
| SG&A Expenses | 565.20K | 614.10K | 724.40K | 814.30K | 716.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 639.60K | 751.10K | 922.70K | 1.03M | 870.40K |
| Operating Income | -589.90K | -751.10K | -875.40K | -1.01M | -870.40K |
| Income Before Tax | -668.80K | -816.60K | -917.30K | -1.04M | -882.20K |
| Income Tax Expenses | -- | -59.60K | -- | -- | -- |
| Earnings from Continuing Operations | -668.80K | -757.00K | -917.30K | -1.04M | -882.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -668.80K | -757.00K | -917.30K | -1.04M | -882.20K |
| EBIT | -589.90K | -751.10K | -875.40K | -1.01M | -870.40K |
| EBITDA | -589.60K | -751.10K | -875.40K | -1.01M | -869.70K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 162.58M | 161.30M | 157.48M | 157.18M | 157.14M |
| Average Diluted Shares Outstanding | 162.58M | 161.30M | 157.48M | 157.18M | 157.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |